Tumorigenicity of four optically active bay-region 3,4-diol 1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine on mouse skin and in newborn mice

被引:12
作者
Chang, RL
Wood, AW
Kumar, S
Lehr, RE
Shirai, N
Jerina, DM
Conney, AH
机构
[1] Rutgers State Univ, Coll Pharm, Canc Res Lab, Piscataway, NJ 08854 USA
[2] Hoffmann La Roche Inc, Roche Res Ctr, Nutley, NJ 07110 USA
[3] SUNY Coll Buffalo, Environm Res Ctr, Div Environm Toxicol & Chem, Buffalo, NY 14222 USA
[4] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA
[5] NIDDKD, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1093/carcin/21.11.1997
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The nitrogen heterocycle dibenz[c,h]acridine (DB[c,h]ACR) and the enantiomers of the diastereomeric pair of bay-region 3,4-diol 1,2-epoxides as well as other bay-region epoxides and dihydrodiol derivatives of this hydrocarbon have been evaluated for tumorigenicity on mouse skin and in the newborn mouse. On mouse skin, a single topical application of 50 or 200 nmol of compound was followed 10 days later by twice-weekly applications of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate for 20 weeks. DB[c,h]ACR and the four optically pure, bay-region 3,4-diol-1,2-epoxide isomers all had significant tumor-initiating activity, The isomer with (1R,2S,3S,4R) absolute configuration [(+)-DE-2] was the most active diol epoxide isomer, The (-)-(3R,3R)-dihydrodiol of DB[c,h]ACR, the expected metabolic precursor of the bay-region (+)-DE-2, was 4- to 6-fold more tumorigenic than its corresponding (+)-enantiomer, In tumorigenicity studies in newborn mice, a total dose of 70-175 nmol of DB[c,h]ACR or one of its derivatives was Injected i,p, on days 1, 8 and 15 of life, and tumorigenic activity was determined when the mice were 36-39 weeks old. DB[c,h]ACR produced a significant number of pulmonary tumors and also produced hepatic tumors in male mice. Of the four optically active bayregion diol epoxides, only (+)-DE-2 and (+)-DE-1 with (1R,2S,3S,4R) and (1S,2R,3S,4R) absolute configuration, respectively, produced a significant tumor incidence. At an equivalent dose, the (+)-DE-2 isomer produced severalfold more pulmonary tumors and hepatic tumors than the (+)-DE-1 isomer, The (-)-(3R,4R)-dihydrodiol, metabolic precursor of the bay-region (+)-DE-2, was strongly active and induced an equal number of pulmonary and hepatic tumors as did DB[c,lt]ACR. The (+)-(35,4S) dihydrodiol was less active. The bay-region (+)-(1R,2S)-epoxide of 1,2,3,4-tetrahydro DB[c,h]ACR was strongly tumorigenic in newborn mice whereas its (-)-(1S,2R)-enantiomer was inactive. This contrasts with the data on mouse skin where both enantiomers had substantial tumorigenic activity. In summary, the bay-region (+)-(1R,2S,3S,4R)-3,4-diol 1,2-epoxide of DB[c,h]ACR was the most tumorigenic of the four optically active bay-region diol epoxides of DB[c,h]ACR on mouse skin and in the newborn mouse, These results with a nitrogen heterocycle are similar to earlier data indicating high tumorigenic activity for the R,S,S,R bay-region diol epoxides of several carbocyclic polycyclic aromatic hydrocarbons.
引用
收藏
页码:1997 / 2003
页数:7
相关论文
共 48 条
[21]  
LEVIN W, 1977, CANCER RES, V37, P2721
[22]  
LEVIN W, 1980, J BIOL CHEM, V255, P9067
[23]  
LEVIN W, 1984, CANCER RES, V44, P929
[24]  
LEVIN W, 1986, CANCER RES, V46, P2257
[25]   OXIDATIVE-METABOLISM OF POLYCYCLIC AROMATIC-HYDROCARBONS TO ULTIMATE CARCINOGENS [J].
LEVIN, W ;
WOOD, A ;
CHANG, R ;
RYAN, D ;
THOMAS, P ;
YAGI, H ;
THAKKER, D ;
VYAS, K ;
BOYD, C ;
CHU, SY ;
CONNEY, A ;
JERINA, D .
DRUG METABOLISM REVIEWS, 1982, 13 (04) :555-580
[26]  
NORDQVIST M, 1981, MOL PHARMACOL, V19, P168
[27]   COMPARATIVE SOLVOLYTIC REACTIVITY OF BAY-REGION DIOL EPOXIDES DERIVED FROM DIBENZ[A,J]ANTHRACENE AND DIBENZACRIDINES [J].
SAYER, JM ;
LEHR, RE ;
KUMAR, S ;
YAGI, H ;
YEH, HJC ;
HOLDER, GM ;
DUKE, CC ;
SILVERTON, JV ;
GIBSON, C ;
JERINA, DM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (03) :1177-1185
[28]  
Shimkin M B, 1975, Adv Cancer Res, V21, P1, DOI 10.1016/S0065-230X(08)60970-7
[29]  
SLAGA TJ, 1979, CANCER RES, V39, P67
[30]   SUBSTITUENT EFFECTS IN CHEMICAL CARCINOGENESIS - METHYL-DERIVATIVES OF THE BENZACRIDINES [J].
SMITH, IA ;
SEYBOLD, PG .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1979, 16 (03) :421-425